PPT-Management of cirrhosis Dr

Nowlan Selvapatt Consultant Hepatologist Imperial College Healthcare NHS Trust Overview Understanding the scale of the problem Brief overview of referral pathways Diagnostics in Primary Care. S Department of Health and Human Services brPage 3br What I need to know about Cirrhosis of the Liver NATIONAL INSTITUTES OF HEALTH National Digestive Diseases Information Clearinghouse brPage 4br Contents What is cirrhosis of the liver 1 What are t Directed Readings . In the Classroom. July/August 2013 issue of . Radiologic Technology. Instructions:. This presentation provides a framework for educators and students to use Directed Reading content published in . Associate Professor of Medicine. Division of . Gastroenterology. /Hepatology. University of Utah Health Sciences Center. Referral for Liver Transplantation Evaluation. Last . Updated: . September . 3. KNH 411. Morgan . Deihs. Lydia Dysart. Objectives. Define Cirrhosis . Understand what MELD means. Name 3 SYMPTOMS of Cirrhosis. Name 3 Methods of TREATMENT for Cirrhosis. Background. Teresa (Terri) Wilcox:. AYURVEDIC . TREATMENT . Dr. . Vikram. . Chauhan. is One of the most . Promising . Ayurvedic. doctors in the world. and a senior consultant physician from India. . He has 12 years of international exposure & . Co-formulated . ombitasvir. (OBV)/. paritaprevir. (PTV)/. rironavir. (r) :. 25/150/100 mg QD = 2 tablets. Dasabuvir. (DSV) : 250 mg bid. Objective. SVR. 12. (HCV RNA < 25 IU/ml). TURQUOISE-III . Kelsey Conrad. Annelise. . Chmelik. September 24, 2013. the . Liver. Largest organ in the body. Extremely complex organ. Filters harmful substances from the blood. Makes substances that digests food. grazoprevir. . + . elbasvir. . in genotype 1 with Child-Pugh B cirrhosis. Jacobson IM. . EASL 2015, Abs. O008. Design. Child-Pugh B. GZR . 100 mg + . EBR . 50 mg. GZR 50 mg + EBR 50 mg. Non-cirrhotic. SIRIUS. Phase . 2 . Treatment. . Experienced. Bourliere. M, et al. Lancet Infect Dis. . 2015;15:397-404.. Source: . Bourliere. . M, . et al. . Lancet Infect Dis. 2015;15:397-404.. Ledipasvir-Sofosbuvir in Treatment-Experienced . in genotypes 1 or 3, with or without cirrhosis. >. 18 years. Chronic HCV infection. Genotype 1 or 3. HCV RNA > 10 000 IU. /ml. Treatment-naïve . Cirrhosis assessed by liver biopsy or noninvasive tests. Best of ILC 2018. About these slides. These slides provide highlights of new data presented at the International Liver Congress 2018. Please feel free to use, adapt, and share these slides for your own personal use; however, please acknowledge EASL as the source. This program is s. upported. by educational grants from AbbVie; Gilead Sciences; Janssen Therapeutics; Merck & Co., Inc; and . ViiV. Healthcare. . About These Slides. Please feel free to use, update, and share some or all of these slides in your noncommercial presentations to colleagues or patients. Medical Director, Austin Hepatitis Center. 1. Hepatitis C & PCP’s. 2. LACK OF AWARENESS. LACK OF APPROPRIATE ACTION. Expand Quantitative Landscape Study – Oct 2013 [Gilead Sciences]. 35-50% of PCP believe HCV can be cured. Dec 2019. Liver cirrhosis. Objectives: . Define Cirrhosis.. Recognize the types of cirrhosis.. Recognize the causes and the pathogenic mechanisms leading to cirrhosis.. Describe the pathological findings in cirrhotic livers..